GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daehan New Pharm Co Ltd (XKRX:054670) » Definitions » Sale Of Business

Daehan New Pharm Co (XKRX:054670) Sale Of Business : ₩0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Daehan New Pharm Co Sale Of Business?

Daehan New Pharm Co's sale of business for the three months ended in Dec. 2024 was ₩0 Mil. It means Daehan New Pharm Co gained ₩0 Mil from selling business. Daehan New Pharm Co's sale of business for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0 Mil.

Compared with last quarter (₩0 Mil in Sep. 2024 ), Daehan New Pharm Co gained the same money from selling business in Dec. 2024 (₩0 Mil).


Daehan New Pharm Co Sale Of Business Historical Data

The historical data trend for Daehan New Pharm Co's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daehan New Pharm Co Sale Of Business Chart

Daehan New Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Daehan New Pharm Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Daehan New Pharm Co Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daehan New Pharm Co Sale Of Business Related Terms

Thank you for viewing the detailed overview of Daehan New Pharm Co's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Daehan New Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
1062-4 Namhyeon-dong, Gwanak-gu, Seoul, KOR, 137-851
Daehan New Pharm Co Ltd is a South Korea based company operating in the pharmaceutical sector. It is engaged in producing pharmaceutical products, animal health and nutrition, and bio products. The pharmaceutical products are tertan tab, amloc tab, tarocin SR tab, NP star tab and others. The animal health and nutrition products are starvac, pigcoc for calves, ocean doctor, and others. The bio range of the products by the group are CELRENA serum-free, BMPro serum-free, BMPro-V serum-free, ALyS505NK-EX serum-free and others.

Daehan New Pharm Co Headlines

No Headlines